Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPAGLIFLOZIN Cause Product availability issue? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product availability issue have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.0% of all adverse event reports for DAPAGLIFLOZIN.

9
Reports of Product availability issue with DAPAGLIFLOZIN
0.0%
of all DAPAGLIFLOZIN reports
0
Deaths
1
Hospitalizations

How Dangerous Is Product availability issue From DAPAGLIFLOZIN?

Of the 9 reports, 1 (11.1%) required hospitalization.

Is Product availability issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does DAPAGLIFLOZIN Cause?

Death (2,775) Diabetic ketoacidosis (1,773) Acute kidney injury (982) Off label use (891) Nausea (884) Dehydration (860) Vomiting (838) Dizziness (817) Ketoacidosis (803) Fatigue (785)

What Other Drugs Cause Product availability issue?

RUXOLITINIB (2,142) LISDEXAMFETAMINE DIMESYLATE (1,530) CERTOLIZUMAB PEGOL (1,381) VEDOLIZUMAB (636) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610) METHYLPHENIDATE (444) SECUKINUMAB (399) BIMEKIZUMAB-BKZX (364) LACOSAMIDE (359) BRIVARACETAM (324)

Which DAPAGLIFLOZIN Alternatives Have Lower Product availability issue Risk?

DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DAPAGLIFLOZIN vs DAPRODUSTAT DAPAGLIFLOZIN vs DAPSONE DAPAGLIFLOZIN vs DAPTOMYCIN

Related Pages

DAPAGLIFLOZIN Full Profile All Product availability issue Reports All Drugs Causing Product availability issue DAPAGLIFLOZIN Demographics